News & Events

Media Archive

Feeling No Pain: Hydrocodone Developers OK with FDA Reclassification
Genetic Engineering & Biotechnology News
11/5/2013
FDA approves extended-release, single-entity hydrocodone product
10/25/2013
Statement on Proposed Hydrocodone Reclassification from Janet Woodcock, M.D., Director (CDER)
10/24/2013
Interview with Dr. Travis Mickle, KemPharm Inc., at the 2014 BIO International Convention
Bloomberg

5/8/2013
Unmeltable, Uncrushable: The Holy Grail in Painkillers 
The Wall Street Journal (may require subscription)
5/6/2013
FDA approves abuse-deterrent labeling for reformulated OxyContin
4/16/2013
FDA issues draft guidance on abuse-deterrent opioids
1/9/2013

 

Return to Media Coverage